CYCLACEL PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 USD | -19.68% |
|
+32.45% | -25.09% |
| 02/05 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
| 30/04 | Top Midday Gainers | MT |
Chart calendar Cyclacel Pharmaceuticals, Inc.
cbfdb386f8f8dfc2a7d.Mk1YK49T9KEKn6bJp-ux2NJC_dbieSAo9rHOu9ybx7w.WTg8R95hg5VYreiL6q3jsKIOlrCJNXZrjoGI8L_Qn-1XACBIzDi_9H_Q8w~7990313aacfdd2772af20b09e45910f5
Upcoming events on Cyclacel Pharmaceuticals, Inc.
Past events on Cyclacel Pharmaceuticals, Inc.
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No: 5711 / 11 |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No: 2117 / 8 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No: 518 / 15 |
| 20/03/2024 02:00 am | Q4 2023 Earnings Call |
| 20/03/2024 01:35 am | Q4 2023 Earnings Release |
| 17/03/2024 | Roth Conference |
| 27/02/2024 01:00 am | BIO CEO & Investor Conference |
| 09/01/2024 12:30 am | Biotech Showcase |
| 18/12/2023 | Reverse Split: 1 of 15 |
| 08/12/2023 08:00 pm | Extraordinary Shareholders Meeting |
| 14/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 10/08/2023 01:35 am | Q2 2023 Earnings Release |
| 13/06/2023 09:30 pm | Annual General Meeting |
| 12/05/2023 02:00 am | Q1 2023 Earnings Call |
| 12/05/2023 01:35 am | Q1 2023 Earnings Release |
| 14/03/2023 03:30 am | Roth Conference |
| 13/03/2023 07:30 pm | Oppenheimer Healthcare Conference |
| 07/03/2023 03:00 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,42 0,39 7.97% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,68 -9,42 -2.75% | -10,6 -10,2 -4.7% | -22,9 -23,1 0.75% | -27,7 -25,7 -7.71% | -25,5 -26,3 3.24% | -21,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,13 -8,88 -2.82% | -9,68 -9,25 -4.68% | -22,7 -23,0 1.22% | -25,9 -24,4 -6.29% | -25,6 -26,1 2.17% | -26,9 |
|
Net income Million USD | Released Forecast Spread | -8,03 -7,99 -0.49% | -12,4 -8,41 -47.43% | -19,1 -20,4 6.36% | -21,4 -21,3 -0.4% | -22,8 -23,2 1.72% | -24,9 |
|
EPS USD | Released Forecast Spread | -150 -153 1.96% | -51,3 -38,4 -33.42% | -32,1 -34,6 7.16% | -28,5 -26,7 -6.74% | -26,8 -20,2 -32.25% | -13,4 |
| Announcement Date | 26/02/20 | 25/02/21 | 28/03/22 | 06/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,37 0,00 - | 0,02 0,00 - | 0,03 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,53 -6,71 2.62% | -6,56 -7,15 8.3% | -5,79 -6,98 17.08% | -6,47 -6,79 4.8% | -8,85 -6,94 -27.53% | -7,32 -9,28 21.1% | -5,93 -7,12 16.78% | -6,85 -5,99 -14.3% | -5,36 -6,21 13.73% | -5,57 | -5,41 | -5,36 | -5,36 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,49 -6,72 3.37% | -5,25 -7,27 27.88% | -5,56 -7,07 21.4% | -6,11 -6,83 10.5% | -9,00 -6,78 -32.68% | -7,12 -9,29 23.3% | -6,03 -7,26 16.94% | -6,70 -5,82 -15.16% | -5,69 -6,21 8.31% | -6,56 | -6,68 | -6,79 | -6,91 |
|
Net income Million USD | Released Forecast Spread | -5,34 -6,65 19.68% | -4,16 -7,07 41.17% | -4,63 -5,66 18.24% | -5,15 -6,37 19.27% | -7,47 -6,54 -14.15% | -5,85 -8,42 30.43% | -5,50 -6,59 16.63% | -6,15 -5,26 -16.97% | -5,32 -5,70 6.61% | -6,06 | -6,18 | -6,29 | -6,41 |
|
EPS USD | Released Forecast Spread | -8,10 -10,3 21.17% | -6,30 -10,3 38.69% | -6,90 -8,06 14.42% | -6,30 -7,65 17.65% | -9,00 -7,24 -24.35% | -7,05 -9,95 29.15% | -6,60 -7,55 12.58% | -7,35 -5,45 -34.86% | -6,23 -5,89 -5.71% | -4,75 | -3,44 | -3,20 | -2,59 |
| Announcement Date | 28/03/22 | 11/05/22 | 10/08/22 | 09/11/22 | 06/03/23 | 11/05/23 | 09/08/23 | 13/11/23 | 19/03/24 | - | - | - | - |
More events
Past sector events for Cyclacel Pharmaceuticals, Inc.
| 03/05/2024 04:30 pm | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:32 am | ARDELYX, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 03/05/2024 01:30 am | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYCC Stock
- Calendar Cyclacel Pharmaceuticals, Inc.
